Strides Pharma Science Limited (BOM:532531)
India · Delayed Price · Currency is INR 997.65
+1.75 (0.18%)
At close: Apr 21, 2026
Strides Pharma Science Market Cap
Strides Pharma Science has a market cap or net worth of 91.89 billion as of April 22, 2026. Its market cap has increased by 52.18% in one year.
Market Cap
91.89B
Enterprise Value
108.52B
Revenue
47.26B
Ranking
n/a
PE Ratio
17.97
Stock Price
997.65
Market Cap Chart
Since February 2, 2000, Strides Pharma Science's market cap has increased from 7.49B to 91.89B, an increase of 1,126.21%. That is a compound annual growth rate of 10.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 91.89B | 10.73% |
| Dec 31, 2025 | 82.99B | 36.56% |
| Dec 31, 2024 | 60.77B | 1.87% |
| Dec 29, 2023 | 59.66B | 88.83% |
| Dec 30, 2022 | 31.59B | -21.29% |
| Dec 31, 2021 | 40.14B | -49.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca Pharma India | 213.00B |
| Granules India | 164.48B |
| Rubicon Research | 152.81B |
| Jubilant Pharmova | 143.25B |
| Caplin Point Laboratories | 133.34B |
| CORONA Remedies | 103.87B |
| Viyash Scientific | 90.48B |
| Procter & Gamble Health | 84.35B |